News

National FINUSTE2 study assessed ustekinumab treatment patterns and outcomes in Finnish adult patients with Crohn’s disease.

What is hot in Health Economics and Outcomes Research? Check out Virtual ISPOR Europe 2020! ESiOR is on the podium again.

HIMSS & Health 2.0 European Digital Event offers the newest information and solutions of healthcare. HIMSS, Healthcare Information and Management Systems Society, Inc., focuses on

Let us introduce the brand-new ESiOR look! We wanted to refresh the ESiOR look for it to represent who and what we are in the

Cost-effective Intervention for the Prevention of Cardiovascular Events There has not been much evidence on the cost-effectiveness of approved interventions for the prevention of cardiovascular

Two of ESiOR’s employees, Senior Consultant Saku Väätäinen and Consultant, Market Access Manager Saara Huoponen, have completed their doctoral studies and received doctoral degrees in

We are happy to welcome Dr. Christian Asseburg – Director, Evidence Generation – and Roope Metsä – Junior Consultant! We are thrilled to have our

Web-based interactive estimation app: assessment of potential incidence and cost effects related to intervention​ ​StopDia investment estimation application predicts and visualizes in simple example-type fashion